Evaluating Type 2 Meds, Part 5: SGLT-2 (Sodium-Glucose Co-Transporter 2) Inhibitors

SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.

read more

Get Afrezza for as Low as $4 a Day

Inhaled insulin Afrezza is a great option for a lot of people living with type 1 and type 2 diabetes because it doesn’t involve shots and has a rapid on-rapid off effect. The makers of Afrezza just announced a direct purchase program to help people get it for as little as $4 a day.

read more